Managing Multiple Drug Launches

,
Traditionally Pharma companies used to launch one or two blockbuster assets a year. This resulted in a one-size-fits-all approach to their launches regarding positioning, go-to-market strategy and resourcing. Today the pharmaceutical industry…

Optimizing Life Science Analytical Solutions – Part 2

,
Analytical Solutions are ultimately about improving business performance. If your solution is underutilized, chances are it isn’t useful enough. In our previous blog, we discussed some ways to substantially improve analytics performance for…

Optimizing Life Science Analytical Solutions – Part 1

So you've invested a lot of time and effort in developing a Life Science commercial analytics solution to monitor the market performance of your drug or medical device. Are you getting what you expected from the investment? Obviously, the goal…

How to Choose an Analytics Solution for Your Next Drug Launch

To succeed today, pharmaceutical companies must be highly responsive to rapid changes in customer behavior and market dynamics, especially when introducing a new drug to the market. Many organizations, however, find themselves overwhelmed by…

Procter & Gamble Exec Highlights the Verix Solution

Guy Peri, IT Executive Director of Global Business Services at CPG giant Procter & Gamble, sat down with us to talk about the value-add that Verix business analytics and insights brought to P&G’s business. Peri discusses how challenging…

Verix Helps Bayer Successfully Launch New Oncology Drugs

Bayer HealthCare Pharmaceutical is a large multinational company with 37,700 employees and net sales of €11B. In 2012 Bayer US Pharma was set to launch two new high profile oncology drugs. Managing drug launches is complicated, with incoming…